LGR4, a G Protein-Coupled Receptor With a Systemic Role: From Development to Metabolic Regulation

LGR4, a G Protein-Coupled Receptor With a Systemic Role: From Development to Metabolic Regulation

Leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4/GPR48), a member of the GPCR (G protein-coupled receptors) superfamily, subfamily B, is a common intestinal crypt stem cell marker. It binds R-spondins/Norrin as classical ligands and plays a crucial role in Wnt signaling potentiation...

Full description

Bibliographic Details
Main Authors:	Joanna Filipowska, Nagesha G. Kondegowda, Nancy Leon-Rivera, Sangeeta Dhawan, Rupangi C. Vasavada
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Endocrinology
Subjects:	LGR4 GPCRs (G protein-coupled receptors) Wnt signaling RANKL (Receptor Activator for Nuclear Factor k B Ligand) inflammation NFκB - Nuclear Factor κB
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.867001/full

Similar Items

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
by: Huijiang Liu, et al.
Published: (2022-07-01)

Fermented Sea Tangle (<i>Laminaria japonica</i> Aresch) Suppresses RANKL-Induced Osteoclastogenesis by Scavenging ROS in RAW 264.7 Cells
by: Jin-Woo Jeong, et al.
Published: (2019-07-01)

OPG/RANKL/RANK cytokine system in renal osteodystrophy
by: Ivica Avberšek-Lužnik, et al.
Published: (2007-11-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
by: Hui Liu, et al.
Published: (2021-03-01)

Praeruptorin B inhibits osteoclastogenesis by targeting GSTP1 and impacting on the S-glutathionylation of IKKβ
by: Kebin Xu, et al.
Published: (2022-10-01)

Regulation of TNF-Induced Osteoclast Differentiation
by: Zhenqiang Yao, et al.
Published: (2021-12-01)

An insight in to Paget′s disease of bone
by: Robin Sabharwal, et al.
Published: (2014-01-01)

Alveolar Bone Density Reduction in Rats Caused by Unilateral Nasal Obstruction
by: Xue Wang, et al.
Published: (2019-11-01)

RTCB deficiency triggers colitis in mice by influencing the NF-κB and Wnt/β-catenin signaling pathways
by: Liu Peiyan, et al.
Published: (2024-02-01)

BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells
by: Danny N. Legge, et al.
Published: (2019-03-01)

Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways
by: Xin Zhi, et al.
Published: (2020-11-01)

Madecassic acid suppresses osteoclast differentiation and bone resorption by inhibiting RANKL‐induced NF‐κB, JNK and NFAT signaling pathways
by: Peiru Su, et al.
Published: (2023-12-01)

Cucurbitacin B Down-Regulates TNF Receptor 1 Expression and Inhibits the TNF-α-Dependent Nuclear Factor κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells
by: Eiichi Kusagawa, et al.
Published: (2022-06-01)

Atypical IκB Bcl3 enhances the generation of the NF-κB p52 homodimer
by: Wenfei Pan, et al.
Published: (2022-08-01)

NUCLEAR FACTOR KAPPA B AS A POTENTIAL TARGET FOR PHARMACOLOGICAL CORRECTION ENDOTHELIUM-ASSOCIATED PATHOLOGY
by: Vera Ragulina, et al.
Published: (2017-03-01)

The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
by: Daniela Verzella, et al.
Published: (2022-09-01)

Inhibition of bone resorption by Tanshinone VI isolated from Salvia miltiorrhiza Bunge
by: V. Nicolin, et al.
Published: (2010-05-01)

Nuclear Factor-κB/p65 (Rel A) Is Constitutively Activated in Human Prostate Adenocarcinoma and Correlates with Disease Progression
by: Sanjeev Shukla, et al.
Published: (2004-07-01)

A novel effect of geraniin on OPG/RANKL signaling in osteoblasts
by: Xiaochao Zhang, et al.
Published: (2018-11-01)

α-Synuclein Negatively Regulates Nurr1 Expression Through NF-κB-Related Mechanism
by: Congcong Jia, et al.
Published: (2020-05-01)

Steroid receptor coactivators – their role in immunity
by: Yosi Gilad, et al.
Published: (2022-12-01)

Photoprotective effects of sphingomyelin-containing milk phospholipids in ultraviolet B–irradiated hairless mice by suppressing nuclear factor-κB expression
by: Yejin Ahn, et al.
Published: (2022-03-01)

Bone metabolism in Langerhans cell histiocytosis
by: Athanasios D Anastasilakis, et al.
Published: (2018-07-01)

Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
by: Huang JM, et al.
Published: (2021-11-01)

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling
by: Luodan Zhang, et al.
Published: (2022-11-01)

Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway
by: Maria Magdalena Barreca, et al.
Published: (2023-05-01)

TEST SYSTEM FOR EVALUATION OF THE INFLUENCE OF THE BIOLOGICAL ACTIVITY OF SUBSTANCES ON THE SIGNAL SYSTEM OF NF-κB: FOCUS ON THE DERIVATIVES OF 3-HYDROXYPYRIDINE
by: Sophiya Ya. Skachilova, et al.
Published: (2017-06-01)

Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis
by: Cao Q, et al.
Published: (2023-03-01)

Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways
by: Jiyong Wei, et al.
Published: (2020-07-01)

The effects of dried root aqueous extract of Salvia miltiorrhiza and its major ingredient in acceleration of orthodontic tooth movement in rat
by: Li-qun Xiao, et al.
Published: (2015-10-01)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
by: Qiang Xu, et al.
Published: (2021-06-01)

Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
by: Andrew Paul, et al.
Published: (2018-10-01)

Increased succinate receptor GPR91 involved in the pathogenesis of Mooren’s ulcer
by: Lin Li, et al.
Published: (2018-11-01)

Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
by: Sajad Fakhri, et al.
Published: (2022-03-01)

The Roadmap of RANKL/RANK Pathway in Cancer
by: Sandra Casimiro, et al.
Published: (2021-08-01)

Crosstalk between bone and other organs
by: Yuan Wanqiong, et al.
Published: (2022-08-01)

Cigarette smoke-induced RANKL expression enhances MMP-9 production by alveolar macrophages
by: Zhou L, et al.
Published: (2018-12-01)

Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis
by: Shu-ting Lin, et al.
Published: (2021-08-01)

The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice
by: Xiang Li, et al.
Published: (2019-10-01)